ArticleCirculation reports2026
Association of Non-Severe Aortic Stenosis With Left Ventricular Reverse Remodeling and Clinical Outcomes After Cardiac Resynchronization Therapy.
Article in Circulation reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The clinical impact of non-severe aortic stenosis (AS) on the response to cardiac resynchronization therapy (CRT) remains unclear. We investigated whether non-severe AS affects left ventricular (LV) reverse remodeling and long-term outcomes after CRT. Methods and Results: We retrospectively analyzed 181 consecutive patients with chronic heart failure (mean age 70 years; 76% male) who underwent CRT at a single center. Patients were classified into a non-severe AS group (mild or moderate AS) and a no AS group. The primary endpoint was a composite of all-cause death and heart failure hospitalization. LV reverse remodeling, defined as a ≥15% reduction in LV end-systolic volume at 6 months, was evaluated as a secondary endpoint. Patients with non-severe AS were older and had a higher baseline LV ejection fraction. LV reverse remodeling occurred less frequently in the non-severe AS group (39% vs. 66%; P<0.05). Non-severe AS was independently associated with lower likelihood of LV reverse remodeling. During a median 3.5-year follow up, cumulative incidence of the composite endpoint was higher in the non-severe AS group. In multivariable Cox analysis, non-severe AS independently predicted adverse outcomes (hazard ratio 2.19; 95% confidence interval 1.19-4.16; P=0.01). Conclusions: Non-severe AS is associated with attenuated LV reverse remodeling and worse outcomes after CRT and may represent a modifier of CRT response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.